JULIA O'CONNOR: Open Payments
NPI 1477980712 · CATSKILL, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$521 in 31 payments from 7 companies in 2025. Trend: 2023 $478 · 2024 $556 · 2025 $521
Food & beverage: $521
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $178 |
| GlaxoSmithKline, LLC. | 9 | $159 |
| Lilly USA, LLC | 3 | $55 |
| Abbott Laboratories | 2 | $40 |
| PFIZER INC. | 2 | $35 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| Exact Sciences Corporation | 1 | $24 |
Products named: TRELEGY ELLIPTA, Rybelsus, Ozempic, MOUNJARO, FREESTYLE LIBRE 3, BREZTRI, The Cologuard Plus Collection Kit, PREVNAR 20.
Industry payments across NY — which companies pay providers there.
